An 83-year-old female patient recovered from her primary
Clostridium difficile-associated colitis upon antibiotic
treatment and the suspension of her regular Proton Pump
Inhibitor (PPI) therapy, and had a recurrence of the
infection once PPI was restarted. After the treatment of
the recurrent episode, the PPI was replaced with a
histamine H2 receptor blocker, and she developed no more
relapses. The switch from PPI to a H2 blocker may have
been a recovery factor. More research is encouraged to
clarify the extent of the suggested effect.
Open Access
Peer Reviewed
ISSN: 2381-5078
Aperito Journal of Infectious Disease and Vaccines
International open-access publishing for high-quality research, reviews, case studies, and scholarly communication.
Submit Manuscript
Original Research
Article in Press
Prognosis with Proton Pump Inhibitor Versus H2 Blocker Therapy in Clostridium Difficile Infection
Istvan Varkonyi1*, Olena Misak1, Laszlo Kardos1, Zsolt Lampe1, Zoltan Szilvassy2 and Eva Rakoczi1
Corresponding Author: Istvan Varkonyi,
Received: Mar 24, 2015
Accepted: Apr 06, 2015
Published: Apr 09, 2015
Views: 3
DOI: 10.14437
Abstract
Istvan Varkonyi (2015), Prognosis with Proton Pump Inhibitor Versus H2 Blocker Therapy in Clostridium Difficile
Infection. Aperito J Infect Dis Vaccines 1:106
Copyright:
Copyright: © 2015 AJIDV. This is an open-access article distributed under the terms of the Creative Commons Attribution License, Version 3.0, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and source are credited.
use, distribution, and reproduction in any medium, provided the original author and source are credited.
Indexed In
Google Scholar
DOAJ
PubMed
Scopus